Summary
In the 1985–1994 period, 101 patients underwent resection for ductal pancreatic adenocarcinoma. In 27 patients, the resection was not associated with adjuvant therapies, whereas in 74 patients, it was. Intraoperative radiation therapy (IORT) was performed in 54 patients. Operative mortality and morbidity were similar in patients undergoing IORT (1.8 and 29.6%) to those undergoing resection alone (2.1 and 27.6%). Median survival of the IORT group was 17 vs 14 mo of the non-IORT group (irrespective of postoperative treatments) (ns); the local recurrence rates were 38 and 54%, respectively. The group of 74 patients undergoing adjuvant therapies had a greater survival than 27 patients with no adjuvant treatment, both at the univariate (p<0.01) and the multivariate analyses (p<0.05) (covariates tumor stage and radicality). The subgroup of patients undergoing only radiotherapy (RT) and/or chemotherapy (CT) did not show significantly better survival than patients with no additional therapies, whereas the group of patients undergoing IORT+CT+RT showed a significantly better survival (p<0.05).
In conclusion, adjuvant therapies seem to improve survival in patients undergoing resection for pancreatic cancer.
Similar content being viewed by others
References
Tepper J, Nardi G, Suit H. Carcinoma of the pancreas: review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy.Cancer 1976; 37: 1519–1524.
Griffin JF, Smalley SR, Jewell W, Paradelo JC, Evans RG. Patterns of failure after curative resection of pancreatic carcinoma.Cancer 1990; 66: 56–61.
Hiraoka T. Extended radical resection of cancer of the pancreas with intraoperative radiotherapy.Clin Gastroenterol 1990; 4: 985–993.
Dobelbower RR, Bronn DG. Radiotherapy in the treatment of pancreatic cancer.Clin Gastroenterol 1990; 4: 969–983.
Zerbi A, Fossati V, Parolini D, Carlucci M, Balzano G, Bordogna G, Staudacher C, Di Carlo V. Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer.Cancer 1994; 73: 2930–2935.
Di Carlo V, Chiesa R, Pontiroli AE, Carlucci M, Staudacher C, Zerbi A, Cristallo M, Braga M, Pozza G. Pancreatoduodenectomy with occlusion of the residual stump by Neoprene injection.World J Surg 1988; 13: 105–111.
Kaplan E, Meier P. Non-parametric estimation from incomplete observation.JAMA 1958; 53: 457–481.
Lillemoe KD. Current management of pancreatic carcinoma.Ann Surg 1995; 221: 133–148.
Takahashi S, Ogata Y, Tsuzuki T. Combined resection of the pancreas and portal vein for pancreatic cancer.Br J Surg 1994; 81: 1190–1193.
Gudjonsson B: Cancer of the pancreas: 50 years of surgery.Cancer 1987; 60: 2284–2303.
Trede M, Schwall G, Saeger HD. Survival after pancreato-duodenectomy.Ann Surg 1990; 211: 447–458.
Cameron JL, Crist DW, Sitzmann JV. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.Am J Surg 1991; 161: 120–125.
Whittington R, Bryer HP, Haller DG, Solin LJ, Rosato EF. Adjuvant therapy of resected adenocarcinoma of the pancreas.Int J Radiat Oncol Biol Phys 1991; 21: 1137–1143.
Sindelar WF, Kinsella TJ. Randomized trial of intra-operative radiotherapy in resected carcinoma of the pancreas.Int J Radiat Oncol Biol Phys 1986; 12 (Suppl 2): 148.
Kalser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection.Arch Surg 1985; 120: 899–903.
Bakkevold KE, Arnesjo B, Dahl O, Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater. Results of a controlled, prospective, randomised multicentre study.Eur J Cancer 1993; 29A: 698–703.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Di Carlo, V., Zerbi, A., Balzano, G. et al. Intraoperative and postoperative radiotherapy in pancreatic cancer. International Journal of Pancreatology 21, 53–58 (1997). https://doi.org/10.1007/BF02785920
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02785920